State Key Laboratory for Diagnosis and Treatment of Infectious Disease, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, Zhejiang, People's Republic of China.
Eur J Clin Microbiol Infect Dis. 2012 Jul;31(7):1585-91. doi: 10.1007/s10096-011-1481-x. Epub 2012 Jan 12.
Enterobacter amnigenus (EA76) and Klebsiella pneumoniae (KP76) isolates with multidrug-resistant (MDR) patterns were identified from the same patient in the neurosurgery department of our hospital. An outbreak of MDR K. pneumoniae had also occurred in this department. To characterize the resistance mechanism and molecular epidemiology of these isolates, sequential experiments including antimicrobial susceptibility testing, polymerase chain reaction (PCR), plasmid analysis, pulsed field gel electrophoresis (PFGE), and multilocus sequence typing (MLST) were performed. EA76 and KP76 were resistant to all of the antibiotics tested, except colistin and tigecycline. blaKPC-2, blaTEM-1, blaSHV-12, blaCTX-M-3, blaCTX-M-14, and rmtB genes were identified in both isolates, with blaKPC-2, blaTEM-1, blaCTX-M-14, and rmtB being co-carried on one plasmid in each isolate. Further analysis showed different restriction patterns between the two KPC-carrying plasmids. Of the 11 carbapenem-resistant isolates found in the outbreak, all were resistant to all of the β-lactams tested, with 63.64% (7/11) also exhibiting resistance to aminoglycosides and 72.73% (8/11) exhibiting resistance to quinolones. PCR analysis and molecular typing of the 11 K. pneumoniae strains revealed that the seven aminoglycoside-resistant isolates shared the same antibiotic-resistant gene pattern and identical or one-band-difference PFGE profiles relative to KP76. In addition, all of the eight aminoglycoside-resistant isolates, including KP76, belonged to the national epidemic clone ST11. The overall results indicate the emergence of E. amnigenus and outbreak of ST11 K. pneumoniae, with both co-harboring blaKPC and rmtB genes on a single plasmid in our neurosurgery wards.
从我院神经外科的同一位患者中分离出具有多重耐药(MDR)模式的阴沟肠杆菌(EA76)和肺炎克雷伯菌(KP76)。该科室也曾爆发过 MDR 肺炎克雷伯菌感染。为了研究这些分离株的耐药机制和分子流行病学特征,我们进行了一系列实验,包括药敏试验、聚合酶链反应(PCR)、质粒分析、脉冲场凝胶电泳(PFGE)和多位点序列分型(MLST)。EA76 和 KP76 对除多粘菌素和替加环素以外的所有测试抗生素均具有耐药性。两株菌均携带 blaKPC-2、blaTEM-1、blaSHV-12、blaCTX-M-3、blaCTX-M-14 和 rmtB 基因,其中 blaKPC-2、blaTEM-1、blaCTX-M-14 和 rmtB 基因均位于两株菌各自的一个质粒上。进一步分析显示,两株菌的 KPC 携带质粒具有不同的限制酶图谱。在爆发中发现的 11 株耐碳青霉烯类肺炎克雷伯菌均对所有测试的β-内酰胺类抗生素耐药,其中 63.64%(7/11)对氨基糖苷类药物也耐药,72.73%(8/11)对喹诺酮类药物耐药。对 11 株肺炎克雷伯菌的 PCR 分析和分子分型显示,7 株耐氨基糖苷类肺炎克雷伯菌具有相同的抗生素耐药基因模式和与 KP76 相同或相差 1 条带的 PFGE 图谱。此外,包括 KP76 在内的所有 8 株耐氨基糖苷类肺炎克雷伯菌均属于国家流行克隆 ST11。总体结果表明,阴沟肠杆菌和携带 blaKPC 和 rmtB 基因的 ST11 型肺炎克雷伯菌在我院神经外科病房同时出现和爆发。